Accessibility Menu
Humana Stock Quote

Humana (NYSE: HUM)

$291.12
(1.2%)
+3.40
Price as of October 23, 2025, 3:58 p.m. ET

KEY DATA POINTS

Current Price
$291.3
Daily Change
(1.2%) +$3.40
Day's Range
$280.7 - $293.14
Previous Close
$291.3
Open
$283.38
Beta
0.43
Volume
881,696
Average Volume
1,928,345
Market Cap
34.6B
Market Cap / Employee
$287.72M
52wk Range
$206.87 - $315.35
Revenue
-
Gross Margin
-
Dividend Yield
1.23%
EPS
$13.03
CAPs Rating
-
Industry
Healthcare Providers and Services

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Humana Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
HUM+14.2%-31.49%-7.28%+138,413%
S&P+16.23%+94.45%+14.22%+6,711%

Humana Company Info

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

News & Analysis

The Fool has written over 200 articles on Humana.

Financial Health

General

Q2 2025YOY Change
Revenue$32.39B9.6%
Market Cap$29.51B-34.5%
Market Cap / Employee$0.45M0.0%
Employees65.7K-2.8%
Net Income$543.00M-19.9%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$4.04B-26.6%

Liabilities

Q2 2025YOY Change
Long Term Debt$12.59B7.2%
Short Term Debt$0.00M-100.0%

Ratios

Q2 2025YOY Change
Return On Assets3.14%-0.1%
Return On Invested Capital10.48%-2.3%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$1.16B5.3%
Operating Free Cash Flow$1.27B4.8%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Earnings28.0425.4818.7118.76-29.54%
Price to Book2.291.741.951.66-40.45%
Price to Sales0.330.260.270.24-40.42%
Price to Tangible Book Value7.014.836.024.41-52.14%
Price to Free Cash Flow TTM22.0215.5916.3914.69-
Free Cash Flow Yield4.5%6.4%6.1%6.8%-
Return on Equity7.9%7.4%10.1%9.0%-11.58%
Total Debt$13.02B$12.26B$13.31B$12.59B-2.40%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.